Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complex interactions in Parkinson's disease: a two-phased approach.

Demetrius M Maraganore1, Mariza de Andrade, Timothy G Lesnick

  • 1Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. dmaraganore@mayo.edu

Movement Disorders : Official Journal of the Movement Disorder Society
|June 5, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Familial Aggregation of Parkinson Disease and Essential Tremor in Early and Late Onset Parkinson Disease Cohorts.

Neurology·2026
Same author

Long-Term Outcomes in Stiff Person Spectrum Disorder.

European journal of neurology·2026
Same author

Genetic drivers of progression in Alzheimer's disease are distinct from disease risk.

Alzheimer's research & therapy·2026
Same author

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Nature communications·2026
Same author

Identification of common variants influencing risk of the three-repeat tauopathy Pick's disease: a genome wide association study.

medRxiv : the preprint server for health sciences·2026
Same author

Autonomic Dysfunction and Risk of Mortality in Early-Onset Parkinson's Disease.

Annals of neurology·2025

Parkinson's disease (PD) risk is influenced by gene interactions. A study found that for women, specific variants in UCHL1 and alpha-synuclein genes significantly increase PD risk, suggesting a multigenic cause.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Pathogenic mutations in alpha-synuclein, parkin, and UCHL1 genes implicate the ubiquitin proteasome system (UPS) in Parkinson's disease (PD).
  • Polymorphisms in these genes are independently associated with PD risk.
  • Understanding gene interactions is crucial for elucidating PD pathogenesis.

Purpose of the Study:

  • To investigate complex gene-gene interactions among alpha-synuclein, parkin, and UCHL1 in Parkinson's disease.
  • To explore the role of the ubiquitin proteasome system (UPS) in PD etiology through genetic analysis.
  • To identify specific genetic variants and their combined effects on PD susceptibility.

Main Methods:

  • A two-phased approach involving recursive partitioning and logistic regression analyses.

Related Experiment Videos

  • Genotyping of alpha-synuclein, parkin, and UCHL1 genes in 298 PD cases and 185 controls.
  • Statistical analysis to detect epistatic interactions between gene polymorphisms.

    • Main Results:

    • An epistatic interaction between UCHL1 and alpha-synuclein genotypes was observed in women.
    • This interaction significantly increased the risk of Parkinson's disease (odds ratio = 2.42; P = 0.003).
    • No significant interactions were found in the overall cohort or in men.

    Conclusions:

    • Parkinson's disease is likely a multigenic disorder influenced by the ubiquitin proteasome system.
    • Specific gene-gene interactions, particularly between UCHL1 and alpha-synuclein in women, contribute to PD risk.
    • Further research into UPS gene interactions is warranted to understand PD pathogenesis.